CN Patent

CN114907349A — 稠合的氮杂三环类衍生物、其制备方法及其在医药上的应用

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2022-08-16 · 4y expired

What this patent protects

本公开涉及稠合的氮杂三环类衍生物、其制备方法及其在医药上的应用。具体而言，本公开涉及一种通式(I)所示的稠合的氮杂三环类衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂的用途，特别是作为GR调节剂的用途和在制备用于治疗和/或预防肿瘤的药物中的用途。

USPTO Abstract

本公开涉及稠合的氮杂三环类衍生物、其制备方法及其在医药上的应用。具体而言，本公开涉及一种通式(I)所示的稠合的氮杂三环类衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂的用途，特别是作为GR调节剂的用途和在制备用于治疗和/或预防肿瘤的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN114907349A
Jurisdiction
CN
Classification
—
Expires
2022-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.